CDC: Arthritis Limits the Activities of 24 Million U.S. Adults

Share this content:
CDC: Arthritis Limits the Activities of 24 Million U.S. Adults
CDC: Arthritis Limits the Activities of 24 Million U.S. Adults

WEDNESDAY, March 8, 2017 (HealthDay News) -- One in four adults in America report an arthritis diagnosis, with the number of individuals disabled by it up 20 percent since 2002, according to a report from the U.S. Centers for Disease Control and Prevention.

Twenty-four million adults are limited in their everyday activities due to the condition. Almost two of five adults with arthritis are of working age -- 18 to 64 years old, the CDC said. Arthritis costs at least $81 billion in direct medical costs annually. The report also noted that arthritis frequently occurs with other health conditions, namely heart disease, diabetes, or obesity.

"Doctors and loved ones can help people with arthritis by encouraging them to be as physically active as they can be," CDC acting director Anne Schuchat, M.D., said in an agency news release. "Physical activity is a proven strategy to ease pain and reduce symptoms among people with arthritis." Exercise -- such as walking, swimming, or biking -- can reduce symptoms by as much as 40 percent, according to the report.

"It's extremely important for primary care providers to encourage their patients with arthritis to be physically active," epidemiologist Kamil Barbour, Ph.D., of the CDC's National Center for Chronic Disease Prevention and Health Promotion, said in the news release. "It is just as important for them to motivate their patients to attend workshops to learn how to better manage their arthritis." People are more likely to attend an education program if a health care provider recommends it. But to date, only one in 10 Americans has participated in this type of program, the CDC reported.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Single-Payer Health System Bill Moves Forward in California

Single-Payer Health System Bill Moves Forward in California

Not yet clear where money for the single-payer system would come from

Regorafenib Approved for Hepatocellular Carcinoma

Regorafenib Approved for Hepatocellular Carcinoma

It is the first approved treatment for HCC in almost a decade

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab

is free, fast, and customized just for you!

Already a member?

Sign In Now »